News Archives:

Cytochroma Reports Positive Phase Ib Results for Novel Topical Treatment of Psoriasis
August 03, 2005

Cytochroma Reports Successful Efficacy Trial for Novel Topical Treatment of Psoriasis
June 02, 2005

Cytochroma Secures Additional Financing
May 05, 2005

Cytochroma Receives Regulatory Approval to Initiate Human Clinical Trials for New Psoriasis Drug
November 23, 2004

Cytochroma Announces Selection of Compound for Treatment of Psoriasis
September 23, 2003

Cytochroma Inc. Discovers New Retinoic Acid Metabolizing Cytochrome P450
August 21, 2003

Cytochroma Raises $6.5 Million in Third Round of Series B Financing. $22 Million Raised in Total Since the Fall of 2001
December 4, 2002

Cytochroma Appoints World Leading Researchers to Scientific Advisory Board
October 1, 2002

Cytochroma’s Series B Financing Raises $15.5 Million
December 18, 2001

Cytochroma Inc. Discovers Functional Role for an Orphan Cytochrome P450
November 15, 2001

Cytochroma Closes $12 Million Round of Financing
October 29, 2001

Cytochroma Inc. Expands Collaboration with Allergan
July 31, 2001

Cytochroma Inc Appoints Dr. Alan J. Lewis to Board of Directors
July 10, 2001

Cytochroma Inc Licenses Novel Chemical Compounds from Johns Hopkins University
December 5, 2000

Cytochroma Inc. Issued U.S. Patent for Vitamin D Regulating Enzyme
October 23, 2000

Cytochroma Inc. Issued U.S. Patent for Retinoid Metabolizing Protein
September 14, 2000

The Genome Project - An Uneasy Alliance with Industry
April 4, 2000

Cytochroma, Allergan Team Up in Drug Discovery Deal Worth $5 Million
June 1, 1999